The Midlands Engine Investment Fund backed the pharmaceutical sourcing platform to support market testing and team expansion.
"Drug shortages are placing increasing pressure on pharmacists, and disrupting patients’ medical treatments, on a worldwide basis. MEIF investment will allow iethico to re-engineer the medicine procurement process, providing more reliable access to pharmacists and enabling better outcomes for patients."
Midven backed the pharmaceutical sourcing platform through the Midlands Engine Investment Fund.
"Drug shortages are placing increasing pressure on pharmacists, and disrupting patients’ medical treatments, on a worldwide basis. MEIF investment will allow iethico to re-engineer the medicine procurement process, providing more reliable access to pharmacists and enabling better outcomes for patients."
The investment package includes £200k from Finance Yorkshire alongside contributions from the University of Hull and private investors.
"This investment will take MediMusic to the next level. We passionately believe this will be a real game-changer in how we treat dementia patients and people suffering from pain, anxiety and stress."
The Oxford medical technology company secured backing from investors including Mercia and IQ Capital to scale its diagnostic software.
"Following years of research and clinical trials that have shown the impact of our software on the diagnosis of at-risk lung nodules, we’re focused on expanding patient access to this crucial technology and identifying deadly lung cancer faster in more at-risk people. The funding will also boost our research and development with world-leading institutions and partners to progress further innovation."